Analyst Recommendations
15.58 -0.26(-1.64%)07/03/2024
Acadia Pharmaceuticals Inc (ACAD)
Acadia Pharmaceuticals Inc (ACAD)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 12 |
Overweight | 9 |
Outperform | 6 |
Neutral | 4 |
Perform | 3 |
Market Outperform | 1 |
Hold | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades